SBRA · NASDAQ
Sabra Health Care REIT (SBRA) Stock Price & Fundamentals
Sabra Health Care REIT (SBRA) closed at $839.82 on Oct 9, 2026, up 1.28% from the previous close of $829.24.
Share price, past year
1Y +47.28%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $839.82 |
| Sep 30, 2026 | $826.99 |
| Aug 31, 2026 | $781.48 |
| Jul 31, 2026 | $728.36 |
| Jun 30, 2026 | $721.90 |
| May 29, 2026 | $681.71 |
| Apr 30, 2026 | $675.13 |
| Mar 31, 2026 | $635.56 |
| Feb 27, 2026 | $641.34 |
| Jan 30, 2026 | $574.53 |
| Dec 31, 2025 | $560.97 |
| Nov 28, 2025 | $592.60 |
| Oct 31, 2025 | $569.25 |
Key statistics
- Market cap
- $214.54B
- P/E (TTM)
- 3,230.1
- EPS (TTM)
- $0.26
- Revenue (TTM)
- $859.56M
- Net income (TTM)
- $65.44M
- Shares outstanding
- 255.5M
- Dividend yield
- 0.14%
- 52-week range
- $556.01 – $839.82
Sabra Health Care REIT's market cap is $214.54B, based on a share price of $839.82 and 255.5M shares outstanding as of Jun 30, 2026.
Financials
Sabra Health Care REIT reported revenue of $774.63M for fiscal 2025, up 10.15% from fiscal 2024.
Sabra Health Care REIT earned net income of $155.61M in fiscal 2025, a net margin of 20.1%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $774.63M | +10.2% | $155.61M | 20.1% | $0.64 | — |
| FY2024ended Dec 31, 2024 | $703.24M | +8.6% | $126.71M | 18.0% | $0.54 | — |
| FY2023ended Dec 31, 2023 | $647.51M | +3.6% | $13.76M | 2.1% | $0.06 | — |
| FY2022ended Dec 31, 2022 | $624.81M | +9.7% | −$77.61M | −12.4% | −$0.34 | — |
| FY2021ended Dec 31, 2021 | $569.55M | −4.9% | −$113.26M | −19.9% | −$0.52 | — |
| FY2020ended Dec 31, 2020 | $598.57M | −9.6% | $138.42M | 23.1% | $0.67 | — |
| FY2019ended Dec 31, 2019 | $661.74M | +6.2% | $69.00M | 10.4% | $0.37 | — |
| FY2018ended Dec 31, 2018 | $623.41M | +52.7% | $279.08M | 44.8% | $1.51 | — |
| FY2017ended Dec 31, 2017 | $408.28M | +56.7% | $158.38M | 38.8% | $1.40 | — |
| FY2016ended Dec 31, 2016 | $260.53M | — | $70.28M | 27.0% | $0.92 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $235.87M | −$25.20M | −$0.10 |
| Q1 FY2026ended Mar 31, 2026 | $221.75M | $40.88M | $0.16 |
| Q4 FY2025ended Dec 31, 2025 | $211.90M | $27.23M | $0.11 |
| Q3 FY2025ended Sep 30, 2025 | $190.04M | $22.54M | $0.09 |
| Q2 FY2025ended Jun 30, 2025 | $189.15M | $65.54M | $0.27 |
| Q1 FY2025ended Mar 31, 2025 | $183.54M | $40.30M | $0.17 |
| Q4 FY2024ended Dec 31, 2024 | $182.35M | $46.70M | $0.20 |
| Q3 FY2024ended Sep 30, 2024 | $178.00M | $29.79M | $0.13 |
Company profile
- Name
- Sabra Health Care REIT, Inc.
- Ticker
- SBRA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Real Estate Investment Trusts
- Headquarters
- 1781 Flight Way, Tustin, CA 92782
- Incorporated in
- MD
- Fiscal year ends
- December
- SEC CIK
- 0001492298
Recent SEC filings
- Aug 3, 2026
- Aug 3, 2026
- Jul 21, 2026
- Jun 17, 2026
- May 28, 2026
- Apr 29, 2026
- Apr 29, 2026
- Feb 12, 2026
Frequently asked questions
What is Sabra Health Care REIT's stock price?
Sabra Health Care REIT (SBRA) closed at $839.82 on Oct 9, 2026, up 1.28% from the previous close of $829.24.
What is Sabra Health Care REIT's market cap?
Sabra Health Care REIT's market cap is $214.54B, based on a share price of $839.82 and 255.5M shares outstanding as of Jun 30, 2026.
How much revenue does Sabra Health Care REIT make?
Sabra Health Care REIT reported revenue of $774.63M for fiscal 2025, up 10.15% from fiscal 2024.
What is SBRA's P/E ratio?
Sabra Health Care REIT's price-to-earnings ratio is 3,230.1, based on trailing twelve-month diluted EPS of $0.26.
Does Sabra Health Care REIT pay a dividend?
Yes. Sabra Health Care REIT declared $1.20 per share in dividends over the last four quarters, a yield of 0.14%.
Sources and methodology
Fundamentals come from Sabra Health Care REIT, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures